Latest Kaiser Health News Stories
The price of insulin keeps going up. For people with Type 1 diabetes, high prices can be a life-or-death issue. Now a grass-roots movement is pushing for change.
Insurance companies profit from government contracts but are subject to little oversight of how they spend the money or care for patients. The expansion of Medicaid under the Affordable Care Act has only exacerbated the problem.
A DaVita subsidiary will pay $270 million over allegations that it cheated the federal government for years.
Alec Raeshawn Smith was 23 when diagnosed with Type 1 diabetes, and 26 when he died. He couldn’t afford $1,300 per month for his insulin and other diabetes supplies. So he tried to stretch the doses.
The number of diabetes drug prescriptions filled for low-income people enrolled in Medicaid rose sharply in states that expanded eligibility for the program under the Affordable Care Act, according to a new study.
The vaccine, BCG, is relatively cheap. But experts caution the therapy could be overhyped and, if proven effective, wind up overpriced.
In a major coup for the beverage industry, California lawmakers agreed to ban cities and counties from adopting soda taxes for the next 12 years. In exchange, the beverage industry agreed to pull an initiative off the November ballot that, if passed, would have made it much harder for local governments to raise taxes.
A small group of insurers offers some members with serious illnesses medically tailored meals to improve their health.
Self-management classes can help the tens of millions of Americans now diagnosed with Type 2 diabetes. But the education can come with a high price tag.
On April 1, Medicare launched a major initiative — a diabetes prevention program for seniors and people with serious disabilities— that is available in only a few cities.
A Bay Area public health campaign harnesses the power of poetry to confront the root causes of a diabetes epidemic that is disproportionately hitting minority youth and those from low-income homes.
Kaiser Health News Editor-in-Chief Elisabeth Rosenthal discusses drug costs with Scott Simon, the host of NPR’s Weekend Edition. Listen to the broadcast and read a transcript of that conversation.
Over the past two years, a powerful federal prosecutor and several state attorneys general have launched investigations related to diabetes drugs.
From infections linked to the storm to trying to treat people with chronic diseases in damaged clinics, health officials on this American territory struggle to stay ahead of the needs.
The market for wound care products booms among a growing older and diabetic patient pool, but many treatments are untested and funding for research falls short.
Some health plans are beginning to offer free maintenance care for people with chronic health problems, hoping that spending a little more early on will save a lot of money in the long run.
Medicare is trying to deter overuse of hyperbaric therapy, and some experts question its effectiveness for healing diabetic wounds, one of the treatment’s fastest-growing uses.
This year’s American Diabetes Association scientific meeting came with a hefty price — a policy of no photography and limits on social media. That did not go over well on Twitter.
With the cost of medications up 300 percent in the past decade, supporters see this as a first step to rein in prices.
An analysis of claims data from 60 health insurers found a significant increase in the amount of treatments sought by young people for conditions traditionally associated with older people, such as high blood pressure and sleep apnea.